Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: The EURODIAB Prospective Complications Study

Diabetes Care

Volumn 28, Issue 6, 2005, Pages 1383-1389

  Van Hecke, Manon V ^a,b   Dekker, Jacqueline M ^b   Stehouwer, Coen D A ^b,c   Polak, Bettine C P ^a,b   Fuller, John H ^d   Sjolie, Anne Katrin ^e   Kofinis, Athanasios ^f   Rottiers, Raoul ^g   Porta, Massimo ^h   Chaturvedi, Nish ⁱ  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f HIPPOKRATION HOSPITAL   (Greece)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EUROPE; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROLIFERATIVE RETINOPATHY; PROSPECTIVE STUDY; RISK FACTOR;

EID: 19944361860     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.6.1383     Document Type: Article

References (33)

1. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CD: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 19: 617-624, 1999
2. Dinneen SF, Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 157:1413-1418, 1997
3. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J: A Prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16:996-1003, 1993
4. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 117:1487-1495, 1999
5. Rajala U, Pajunpaa H, Koskela P, Keinanen-Kiukaanniemi S: High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care 23:957-961, 2000
6. Hanis CL, Chu HH, Lawson K, Hewettemmett D, Barton SA, Schull WJ, Garcia CA: Mortality of Mexican Americans with NlDDM: retinopathy and other predictors in Starr County, Texas. Diabetes Care 16: 82-89, 1993
7. van Hecke MV, Dekker JM, Nijpels G, Moll AC, van Leiden HA, Heine RJ, Bouter LM, Stehouwer CDA, Polak BCP: Retinopathy is associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects: the Hoorn Study (Letter). Diabetes Care 26:2958, 2003
8. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 19:1445-1448, 1996
9. Klein R, Moss SE, Klein BEK, Demets DL: Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 149: 266-272, 1989
10. Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller JH: Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 27:530-537, 2004
11. Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, Moss SE, Reinke JO: Cardiovascular disease, mortality, and retinal microvascular charcteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 164:1917-1924, 2004
12. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA, Polak BCP: Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121:245-251, 2003
13. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, Kohner EM: Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 24:284-289, 2001
14. Fuller JH, Stevens LK, Wang SL: Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44 (Suppl. 2):S54-S64, 2001
15. Stephenson J, Fuller JH: Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278-285, 1994
16. Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B: Cardiovascular disease and its risk factors in IDDM in Europe: EURODIABIDDM Complications Study Group. Diabetes Care 19:689-697, 1996
17. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK: Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 38:437-444, 1995
18. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413-2446, 1997
19. Bucolo G, David H: Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 19:476-482, 1973
20. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW: Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075-1080, 1983
21. Warnick GR, Albers JJ: Comprehensive evaluation of heparin manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J Lipid Res 19:65-76, 1978
22. John WG, Gray MR, Bates DL, Beacham JL: Enzyme immunoassay: a new technique for estimating hemoglobin AlC. Clin Chem 39:663-666, 1993
23. Friedewald WT, Levy RI, Fredrickson DS: Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18:499-502, 1972
24. Kearney EM, Mount JN, Watts GF, Slavin BM, Kind PRN: Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyzer. J Clin Pathol 40:465-468, 1987
25. Klein R, Marino EK, Kuller LH, Polak JF, Tracy RP, Gottdiener JS, Burke GL, Hubbard LD, Boineau R: The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol 86:84-90, 2002
26. Klein R, Sharrett AR, Klein BEK, Moss SE, Folsom AR, Wong TY, Brancati FL, Hubbard LD, Couper D: The association of atherosclerosis, vascular risk factors, and retinopathy in adult's with diabetes: the Atherosclerosis Risk in Communities Study. Ophthalmology 109:1225-1234, 2002
27. Chakrabarti S, Cukiernik M, Hileeto D, Evans T, Chen S: Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 16:393-407, 2000
28. Singh R, Barden A, Mori T, Beilin L: Advanced glycation end-products: a review. Diabetologia 44:129-146, 2001
29. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126, 1999
30. Jager A, van Hinsbergh VWM, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CDA: von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn study. Arterioscler Throm Vasc Biol 19: 3071-3078, 1999
31. Stehouwer CDA, Gall MA, Twisk JWR, Knudsen E, Emeis JJ, Parving HH: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51:1157-1165, 2002
32. Matsumoto K, Sera Y, Ueki Y, Inukai G, Niiro E, Miyake S: Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabet Med 19:822-826, 2002
33. Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD: Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 26:2165-2173, 2003